News | The Biotech Times

Featured Articles

Diagnostics

Digital Health

Medical Devices

Circle CVI joins EXIT-CVD consortium to advance AI cardiac imaging

Circle CVI joins a 42-partner, EUR 27.6m European consortium running 22 cardiovascular studies across 17 countries, contributing its AI imaging platform.

Circle CVI joins a 42-partner, EUR 27.6m European consortium running 22 cardiovascular studies across 17 countries, contributing its AI imaging platform.

The Biotech Times Editorial Team · 21 October 2026
Pharmaceuticals

Biologics

Ascentage Pharma's lisaftoclax wins China BTD for first-line CLL/SLL

China's NMPA has granted lisaftoclax Breakthrough Therapy Designation in combination with acalabrutinib for treatment-naïve CLL/SLL patients.

China's NMPA has granted lisaftoclax Breakthrough Therapy Designation in combination with acalabrutinib for treatment-naïve CLL/SLL patients.

The Biotech Times Editorial Team · 21 October 2026
Pharmaceuticals

Biologics

Coultreon's COL-5671 shows mAb-comparable TNFα inhibition in Phase 1

Coultreon Biopharma presented final Phase 1 data on its oral SIK3 inhibitor at UEGW 2026, with Phase 2 psoriasis recruitment set for Q4 2026.

Coultreon Biopharma presented final Phase 1 data on its oral SIK3 inhibitor at UEGW 2026, with Phase 2 psoriasis recruitment set for Q4 2026.

The Biotech Times Editorial Team · 21 October 2026
Medical Devices

Biologics

Pharmaceuticals

Enable Injections wins first Japan approval for enFuse on-body injector

Japan's MHLW has cleared the CirCLIQ injector for Sanofi's isatuximab SC formulation, making it the first anticancer therapy delivered via an on-body

Japan's MHLW has cleared the CirCLIQ injector for Sanofi's isatuximab SC formulation, making it the first anticancer therapy delivered via an on-body

The Biotech Times Editorial Team · 21 October 2026
Pharmaceuticals

Biologics

Roche to present divarasib, giredestrant and Tam-Peli data at ESMO 2026

Roche heads to ESMO 2026 with Phase III readouts across KRAS G12C lung cancer, early breast cancer and a next-generation B7-H3 ADC.

Roche heads to ESMO 2026 with Phase III readouts across KRAS G12C lung cancer, early breast cancer and a next-generation B7-H3 ADC.

The Biotech Times Editorial Team · 20 October 2026

Medical Devices

Saudi Arabia Reframes Healthcare as Strategic Investment for Innovation

Saudi Arabia’s KFSHRC leads with AI, robotics, and precision medicine, supporting Vision 2030 and global collaboration in sustainable healthcare systems.

H.E. Dr. Majid Alfayyadh urges viewing healthcare as a driver of security, prosperity, and innovation.

The Biotech Times Editorial Team · 23 October 2025

Medical Devices

Hub71 + Life Sciences: Abu Dhabi’s Next Chapter in Healthcare Innovation

Discover how Hub71’s new Life Sciences vertical is transforming Abu Dhabi into a global hub for biotechnology, digital health, and medical innovation — with startups like Bio Sapien and E

The Biotech Times Editorial Team · 23 October 2025

Medical Devices

Prosper AI Raises $5M to Automate Healthcare’s Administrative Burden

Prosper AI secures $5M seed funding to scale its healthcare-specialized voice AI agents, automating patient and payer calls, reducing costs, and improving efficiency for hospitals, billin

The Biotech Times Editorial Team · 15 October 2025

Medical Devices

Ant Group Expands AI Healthcare & Finance Services in China

Ant Group’s AQ app launches AI updates to improve healthcare access nationwide, while Ant Fortune opens AI tools for financial institutions, bridging urban-rural gaps and empowering docto

The Biotech Times Editorial Team · 3 October 2025

UK Tech Funding Hits $7.8B in H1 2025, Ranks 2nd Globally

Tracxn reports $7.8B in UK tech funding for H1 2025, driven by strong late-stage deals and sectoral growth in FinTech, Media, and Enterprise.

The Biotech Times Editorial Team · 3 July 2025

Digital Health

e& Enterprise and LifeBot Partner to Deliver Advanced Telemedicine Across UAE

e& enterprise teams up with LifeBot to bring ICU-grade telemedicine to remote areas in the UAE, enhancing healthcare access with real-time diagnostics and sustainable, high-performanc

The Biotech Times Editorial Team · 8 May 2025

Medical Devices

MBZUAI Leads AI Innovations to Improve Maternal and Newborn Health

Mohamed bin Zayed University of AI is

The Biotech Times Editorial Team · 25 April 2025

Medical Devices

e& Enterprise Partners with RAIN Technology to Revolutionize OR Workflows in MEA

e& Enterprise teams up with RAIN Technology to launch Orva, an AI-powered voice assistant, transforming operating room workflows and

The Biotech Times Editorial Team · 8 April 2025

Medical Devices

AI Revolutionizes Healthcare Delivery: Insights from Arab Health 2025

The integration of Artificial Intelligence (AI) into healthcare is redefining patient care and advancing medical outcomes, as demonstrated by insights from the inaugural Digital Health &a

The Biotech Times Editorial Team · 28 January 2025

Medical Devices

Nelly Announces EUR 50 Million Series B Funding Round to Revolutionize Financial Operations in Healthcare

Berlin-based health and fintech company Nelly has raised €50 million. With this Series B financing, the company aims to accelerate the digitalization of the European healthcare sector.

The Biotech Times Editorial Team · 15 January 2025

Medical Devices

Ant Group to Connect 280,000 Doctors on Haodf Healthcare Platform with 800 Million Healthcare Users

Following Ant Group’s acquisition of Haodf, a leading healthcare platform specializing in online doctor consultations, Ant Group President Cyril Han and Haodf.com Founder Hang Wang jointl

The Biotech Times Editorial Team · 13 January 2025

Medical Devices

KLAIM and Wio Bank Unveil Strategic Partnership to Unlock Cash Flow Solutions for UAE Healthcare Providers

Klaim, an Abu Dhabi-based fintech company, and Wio Bank PJSC, the region’s first platform bank, are pleased to announce the launch of an innovative cash-flow solution for healthcare provi

The Biotech Times Editorial Team · 5 December 2024

Subscribe to

Featured Articles

H.E. Dr. Majid Alfayyadh urges viewing healthcare as a driver of security, prosperity, and innovation.

Discover how Hub71’s new Life Sciences vertical is transforming Abu Dhabi into a global hub for biotechnology, digital health, and medical innovation — with startups like Bio Sapien and E

Prosper AI secures $5M seed funding to scale its healthcare-specialized voice AI agents, automating patient and payer calls, reducing costs, and improving efficiency for hospitals, billin

Ant Group’s AQ app launches AI updates to improve healthcare access nationwide, while Ant Fortune opens AI tools for financial institutions, bridging urban-rural gaps and empowering docto

Tracxn reports $7.8B in UK tech funding for H1 2025, driven by strong late-stage deals and sectoral growth in FinTech, Media, and Enterprise.

e& enterprise teams up with LifeBot to bring ICU-grade telemedicine to remote areas in the UAE, enhancing healthcare access with real-time diagnostics and sustainable, high-performanc

Mohamed bin Zayed University of AI is

e& Enterprise teams up with RAIN Technology to launch Orva, an AI-powered voice assistant, transforming operating room workflows and

The integration of Artificial Intelligence (AI) into healthcare is redefining patient care and advancing medical outcomes, as demonstrated by insights from the inaugural Digital Health &a

Berlin-based health and fintech company Nelly has raised €50 million. With this Series B financing, the company aims to accelerate the digitalization of the European healthcare sector.

Following Ant Group’s acquisition of Haodf, a leading healthcare platform specializing in online doctor consultations, Ant Group President Cyril Han and Haodf.com Founder Hang Wang jointl

Klaim, an Abu Dhabi-based fintech company, and Wio Bank PJSC, the region’s first platform bank, are pleased to announce the launch of an innovative cash-flow solution for healthcare provi

Subscribe to The Biotech Times